Please note: This trial has finished recruiting and is not accepting new participants.

Research Center: CaPPRe
Location: Australia
Lead Researchers: Dr Kim Hamrosi and Dr Simon Fifer
Ethics Committee: This study has been reviewed and approved by the Bellberry Human Research Ethics Committee

Researcher interview: 

Background

Chronic Obstructive Pulmonary Disease (COPD) affects one in seven Australians aged 40 or over. Evidence suggests that an early diagnosis combined with proper treatment can reduce the COPD symptoms and improve quality of life.

This study is exploring the treatment issues facing COPD patients and understanding what is important to them.

Australian men and women who have COPD are invited to complete a 20- minute online survey. Participants that meet the eligibility criteria (see below) and complete the entire survey will receive $25 for their time and contribution to the research.

Benefits of Participation

• You will be helping to advance COPD medical research.
• You will receive $25 for your time and contribution to the research.

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women who have COPD
• Able to complete a 20-minute online survey

*Further eligibility criteria apply